Metrion Biosciences are attending the Virtual Nanion User Meeting to be held on 12th to 16th October 2020. Metrion's CSO Dr Marc Rogers will be presenting a talk at the event on 14th October entitled: Development and validation of ASIC1a ligand-gated ion channel drug discovery assays on automated patch clamp platforms. Abstract: Whilst voltage-gated ion [...]
Introducing Damian Bell: as a new member of the team at Metrion we are using an abridged version of an interview by Artem Kondratskyi for ionchannellibrary.com. A big thank you to Artem for sharing this interview and a quick plug for his website – we highly recommend it as an excellent resource for anyone [...]
Thank you to the ELRIG Committee and to BioStrata for allowing us to share the below content on our website. The British Pharmacological Society (BPS) ran a special symposium at the ELRIG Drug Discovery 2019 conference yesterday, focused on the importance of targeting ion channels for drug discovery. As a unique platform to foster the [...]
Dr Edward Humphries will be presenting at the Sophion Japanese User meeting on Friday 11th October to be held at the Knowledge Capital Conference Rooms at the Grand Front, Osaka. Edd's talk is entitled: "Advancing Cardiac Safety Screening on the QPatch" Edd will be at the User meeting all day and will be available to [...]
Overview The Metrion Biosciences team have recently produced a second application note in collaboration with Sophion Bioscience, describing the use of a ∆KPQ LQT3 mutant to create and validate a Nav1.5 (Late) cardiac safety assay on QPatch 48. Herein, we aim to provide a more reliable and accurate Nav1.5(Late) assay, which removes the requirement [...]
